Lung Cancer Screening

個数:
  • ポイントキャンペーン

Lung Cancer Screening

  • ウェブストア価格 ¥17,904(本体¥16,277)
  • Thieme Medical Publishers Inc(2017/11発売)
  • 外貨定価 US$ 81.00
  • 【ウェブストア限定】ブラックフライデーポイント5倍対象商品(~11/24)※店舗受取は対象外
  • ポイント 810pt
  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 120 p.
  • 言語 ENG
  • 商品コード 9781626235137
  • DDC分類 616

Full Description

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.

Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.



The evolution and future of lung cancer screenings
Detection and management of unexpected incidental pulmonary and non-pulmonary findings
Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings
Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates

This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.

Contents

1 Lung Cancer Epidemiology
2 Risk Factors for Lung Cancer
3 Evolution of Lung Cancer Screening
4 Lung Cancer Screening Pros and Cons
5 Variable Imaging Presentations of Lung Cancer
6 Lung Cancer-Screening Results Reporting
7 Detection and Management of Unexpected Incidental Pulmonary and Nonpulmonary Findings
8 Elements of a Successful Lung Cancer-Screening Program
9 Future of Lung Cancer Screening
10 Test Cases: Applying Lung CT Screening Reporting and Data System (Lung-RADS)

最近チェックした商品